Drug Metabolism in Drug Development: A DIA Tutorial for Regulatory Affairs Specialists


Many drug metabolism, drug-drug interaction, and pharmacogenetics meetings are held each year and are well attended by scientists from the pharmaceutical industry, academia, and worldwide regulatory agencies. Personal communication indicated that large amounts of drug metabolism information passed across the desks of the regulatory affairs specialists either as reports being submitted to or as information requests from regulatory agencies and that, unlike other preclinical or clinical data, there was little appreciation of the meaning or relevance of such information to the overall drug development campaign. The purpose of the tutorial described here was to allow regulatory affairs specialists to gain a working appreciation of the nomenclature, techniques, and usefulness of in vitro and in vivo drug metabolism studies.

This is a preview of subscription content, access via your institution.


  1. 1.

    Peck CC, Temple R, Collins JM. Understanding the consequences of concurrent therapies. JAMA. 1993; 269:1150–1152.

    Article  Google Scholar 

  2. 2.

    Monahan BP, Ferguson CL, Killeavey ES, Lloyd BK, Troy J, Cantilena LR. Torsades de pointes occurring in association with terfenadine use. JAMA. 1990;264: 2788–2790.

    CAS  Article  Google Scholar 

  3. 3.

    Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA. 1993;269:1513–1518.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Peter K. Honig MD, MPH.

Additional information

This tutorial was held in conjunction with the DIA 32nd Annual Meeting “The Challenge of Worldwide Pharmaceutical Development in an Era of Regulatory Change: Accelerated Approval with Quality and Contained Cost,” June 9–13, 1996, San Diego, California.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Honig, P.K., Cantilena, L.R. & Santone, K.S. Drug Metabolism in Drug Development: A DIA Tutorial for Regulatory Affairs Specialists. Ther Innov Regul Sci 32, 163–167 (1998). https://doi.org/10.1177/009286159803200123

Download citation

Key Words

  • Metabolism
  • Cytochrome P450
  • Inhibition
  • Induction
  • Polymorphism